An aerosol delivery system that includes an aerosol generator that aerosolizes a fluid for delivery to a patient as a patient inhales. The aerosol delivery system includes a pump coupled to the aerosol generator that pumps the fluid to the aerosol generator, and a breath sensor that emits a signal as the patient breathes. A controller couples to the aerosol generator, the pump, and the breath sensor. In operation, the controller receives the signal from the breath sensor, controls a flow of fluid to the aerosol generator in response to the signal, and controls the aerosol generator to start aerosolizing the fluid before the patient inhales.

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

A medicament delivery device (“MDD”) having a delivery tube and a laryngeal mask having an anterior patient-contacting surface. In some embodiments of the invention, the laryngeal mask has an epiglottis-holding ridge. In some embodiments of the invention, the laryngeal mask has a cuff-portion providing at least a portion of an anterior patient-contacting surface, the cuff-portion being shaped and positioned to create a side-groove facing away from the anterior patient-contacting surface. In some embodiments of the invention, the laryngeal mask has a plurality of ridges on a posterior-side of the laryngeal mask opposite the anterior patient-contacting surface (the “posterior-side ridges”), the posterior-side ridges being shaped and positioned relative to the anterior patient-contacting surface so as to push against the patient and thereby push the anterior patient-contacting surface against the patient.

A pressure regulating device for use with a breathing assistance and/or resuscitation apparatus, which conveys gases along a gases pathway to a patient, includes a mounting for connecting the pressure regulating device to a first outlet in fluid communication with the gases pathway. The mounting holds a valve member that selectively blocks, at least in part, the first outlet. A control member can be manipulated to adjust a property of the valve member. The valve member at least partially blocks the first outlet when the pressure of gases in the pathway is below a selected level, and allows at least a portion of the gases to flow out of the first outlet when the pressure of said gases is above the selected level. The property includes a selected level of pressure whereby manipulation of the control member adjusts the level of pressure between a maximum level and a minimum level.

An aerosol delivery system that includes an aerosol generator that aerosolizes a fluid for delivery to a patient as a patient inhales. The aerosol delivery system includes a pump coupled to the aerosol generator that pumps the fluid to the aerosol generator, and a breath sensor that emits a signal as the patient breathes. A controller couples to the aerosol generator, the pump, and the breath sensor. In operation, the controller receives the signal from the breath sensor, controls a flow of fluid to the aerosol generator in response to the signal, and controls the aerosol generator to start aerosolizing the fluid before the patient inhales.

An aerosol delivery system that includes an aerosol generator that aerosolizes a fluid for delivery to a patient as a patient inhales. The aerosol delivery system includes a pump coupled to the aerosol generator that pumps the fluid to the aerosol generator, and a breath sensor that emits a signal as the patient breathes. A controller couples to the aerosol generator, the pump, and the breath sensor. In operation, the controller receives the signal from the breath sensor, controls a flow of fluid to the aerosol generator in response to the signal, and controls the aerosol generator to start aerosolizing the fluid before the patient inhales.

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

Various embodiments disclosed relate to drug-coated balloon catheters for treating strictures in body lumens and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent.

Various embodiments disclosed relate to drug-coated balloon catheters for treating, preventing, or reducing the recurrence of a stricture and/or cancer, or for treating benign prostatic hyperplasia (BPH), in a non-vascular body lumen and methods of using the same. A drug-coated balloon catheter for delivering a therapeutic agent to a target site of a body lumen stricture includes an elongated balloon having a main diameter. The balloon catheter includes a coating layer overlying an exterior surface of the balloon. The coating layer includes one or more water-soluble additives and an initial drug load of a therapeutic agent. In some embodiments, the balloon catheter includes a length-control mechanism which stretches and elongates the balloon when it is in a deflated state, giving the balloon a smaller cross-sectional deflated profile for tracking through the body lumen and for removal after treatment.

A nasal cannula system having nasal prongs with an ancillary delivery system for a treatment fluid into a patient wearing the nasal cannula without removing the cannula. The nasal prongs have parallel ports that fluidly connect the delivery system to the nasal ports on the nasal prongs. The delivery system provides the treatment fluid in an aerosolized form. This configuration combines the aerosolized treatment fluid with the air or other fluid ordinarily delivered by the nasal cannula. The system may also use airway tubes having a generally semi-circular cross-section with an internal rib extending the length of the tube. The semi-circular cross-section provides a flat exterior surface for abutment or contact with a patient's skin and the rib prevents pinching closure of the airway tube.